Changing diabetes in children
A great initiative to manage type 1 diabetes in children of Bangladesh
Novo Nordisk, a leading pharmaceutical company in diabetic care has extended their worldwide programme of free insulin and diabetes care for the children in Bangladesh. The programme entitled "Changing Diabetes in Children", a 5-year project is a joint initiative of Novo Nordisk and the Diabetic Association of Bangladesh, supported by the funds from Take Action Programme of the Netherlands affiliate and World Diabetes Foundation (WDF). Bangladesh is the sixth country to get diabetes care including free insulin for children with type-1 diabetes under this programme. The programme was launched at BIRDEM Hospital, Dhaka. Mr. Sanjeev Shishoo, Vice President, Regional Office Novo Nordisk and Mbelenge Mapoko Illando, Director, Global Changing Diabetes Programme in the presence of Einar Hebogård Jensen Ambassador, Royal Embassy of Denmark, Prof A K Azad Khan President, Diabetic Association of Bangladesh, Mr Melvin Oscar D'Souza, Managing Director, Regional Office of Novo Nordisk, India, Mr. Rajan Kumar, Country Manager of Novo Nordisk, Bangladesh were present in the launching ceremony. The programme has been set to help 700 children living with type-1 diabetes in Bangladesh. Most of these children will be from poor socioeconomic background and their families can not afford to pay for their diabetes care and insulin. The project includes setting up of three dedicated paediatric diabetes clinics for diagnosis and treatment of children with type-1 diabetes. In addition to basic diabetes care and free insulin, the clinics will also provide patient education, registration and training for healthcare professionals. In partnership with LifeScan Inc., the project will provide blood glucose monitoring supplies (glucometers and strips) to children enrolled in the programme. JMI Banlga Co. will support with their insulin syringe. "Currently, children with diabetes are managed primarily by adult diabetes clinics or general medical outpatient clinics, but treating diabetes of children is not the same as treating diabetes of adults," says Professor Azad Khan, president of Diabetic Association of Bangladesh. Parents of children with type-1 diabetes are requested to enrol their children's name to get the services that will deliver under this project. The official registry will open very soon at BIRDEM Hospital. Until then, parents can register their children's name in Novo Nordisk Pharma Pvt Ltd. @ Tel No: +880 2 9893701.
For all latest news, follow The Daily Star's Google News channel.
Comments